|
Pamiparib Clinical Trials
2 actively recruiting trials across 1 location
Also known as: BGB-290
Other1 trial
Chicago, Illinois1 trial
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
The University of Chicago
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.